Navigation Links
Arcadia Resources Announces First Quarter Results
Date:8/13/2009

ds.

  • Services: The Company's Services segment, which includes its home health care and medical staffing business, reported net revenues of $22.7 million for the quarter compared to net revenues of $25.0 million for the same period a year ago. Within the Services segment, home health care revenues increased by $0.8 million, or 4.7%, to $17.7 million, compared to net revenue of $16.9 million the same period last year. This increase was offset by the decline in medical staffing revenue to $5.0 million in the current quarter, compared with $8.1 million during the first quarter of fiscal 2009. Per diem staffing revenue and travel nurse staffing revenue declined 35% and 45%, respectively, compared to the same period a year ago. Gross margins remained constant at 30.5% compared with 30.4% for the same period last year.

Management's Outlook

"Our management team is focused on improving our operational performance in four key areas," said Steven Zeller, Arcadia's Chief Operating Officer. "These are growth in our Services revenue despite difficult medical staffing market conditions; enrolling and servicing our increasing population of DailyMed customers; improving our Pharmacy segment gross margins; and aligning our selling, general and administrative (SG&A) expenses with our current business focus and lower revenue base. While our first quarter results were mixed in these areas, we are making measurable progress and are confident we have the right plans in place to achieve our objectives during the course of the year."

In its Services segment, Arcadia is projecting that its fiscal 2010 revenue will range from $90 to $100 million, depending significantly on market conditions for medical staffing.

"We continue to see growth in our home care business despite overall economic conditions," Zeller said. "
'/>"/>

SOURCE Arcadia Resources, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Arcadia Completes New Financing; Previews Fourth Quarter Results
2. Arcadia Resources Announces Sale of Non-Strategic Businesses
3. Plane Crash Claims Arcadians Chairman and Founder, John H. Austin M.D.
4. Arcadia Resources Announces Webcast of its Fiscal 2009 Fourth-Quarter and Year-End Conference Call
5. Arcadia Resources Sells Non-Core Software Business
6. Arcadian Management Services Names CEO Robert Fahlman as Chairman of the Board
7. Arcadia Resources Responds to Share Price Volatility
8. Arcadia HealthCare Names Former Walgreens Executive Charles Goodall as Vice President of DailyMed(TM) Pharmacy Operations
9. WellPoint State Sponsored Business Launches New Program with Arcadia HealthCare to Help Improve Medication Safety, Efficacy and Compliance for Medicaid Members
10. Arcadia Resources Announces Fourth Quarter and Fiscal 2009 Year-End Results
11. Arcadian Chairman and Chief Executive Officer, Robert Fahlman, to Present at Focus on Healthcare Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... estimate their 2009 tax return by using the free tax calculator. Answer simple ... ... 2009 -- Taxpayers can estimate their 2009 tax return by using the free ... a child could understand it. No more waiting or worrying about how much ... a handy tool everyone can use., , , Find out right now ...
(Date:12/7/2009)... more emotional and behavioral difficulties when compared to other ... most when a parent is deployed overseas, according to ... having a parent deployed for a longer period of ... with emotional problems were important factors associated with whether ... published online by the journal Pediatrics . , ...
(Date:12/6/2009)... Calif., Dec. 6 Pharmacyclics, Inc. (Nasdaq: ... a Phase I/II study showing safety and clinical ... Lymphoma (NHL) treated with its HDAC inhibitor PCI-24781 ... today at the 51st ASH Annual Meeting being ... ,, PCI-24781 is an oral pan-HDAC inhibitor ...
(Date:12/6/2009)... treatments targeting growth factor, researchers say , , SUNDAY, ... cancer cells from the main tumor to other parts ... known as TGFb, which may prove a promising target ... researchers say. , Previous studies have shown that TGFb ... movement. In this new study, a team from Cancer ...
(Date:12/6/2009)... 6 Sickle cell disease, a condition ... is one of the most common genetic blood ... including more than 70,000 Americans.(1) Research presented today ... Society of Hematology highlights intriguing studies on the ... children with this blood disorder, evaluations of both ...
Breaking Medicine News(10 mins):Health News:2009 Free Tax Return Calculator 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 2Health News:Military children face more emotional challenges as parental deployments grow longer, study finds 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Breast Cancer's Spread Now Better Understood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9
... having a tough time with jail inmates who are poking ... , with ex- beau Rick Salomon. ,A fellow ... saying 'Paris sure knows how to do hard time, we've ... said that prisoners were constantly taunting a sobbing Hilton by ...
... even at the cost of lives, are turning out to ... are far less likely than whites to get specialized ... leave them more vulnerable to future fatal attacks. ... American Medical Association, tracked 1.2 million Medicare patients at least ...
... has helped thousands of disabled worldwide to walk again, is ... foreign soil . ,The Colombian government has sanctioned the ... limb, to set up base in the South American country. ... NGO. ,M.K. Mathur of BMVSS told IANS: "The ...
... shown a significant increase in Northern Ireland since the early ... living in more affluent areas . The study also revealed ... disease. ,Researchers, who looked at official cancer statistics ... 20 per cent increase in patients and a 62 per ...
... that what I "thought" to be a cold was a bronchial ... could wind up in the hospital . But then a good ... because I have life insurance, only I just can't afford to ... the over inflated prices of medical care and prescription medications. I ...
... emphasised the safety and efficacy of Enbrel (etanercept) in ... ,Biologics, such as etanercept, work by blocking ... body called tumour necrosis factor that is involved in ... as an anti-TNF therapy, etanercept has shown to halt ...
Other Medicine News:Health News:Racial Discrimination Takes The Nobility Out Of Doctoring 2Health News:Jaipur Foot All Set to Launch Its Centre in Columbia 2Health News:Deadly Skin Cancer Bites the Rich Harder 2Health News:Deadly Skin Cancer Bites the Rich Harder 3Health News:Ask Right Questions and Save Country from Further Healthcare Crisis: Michael Moore 2Health News:Study Reinforces Safety of Long-term Biologic Treatment for Rheumatoid Arthritis 2
(Date:12/4/2009)... Emergency Deliveries are Transported ,, PHILADELPHIA, Dec. ... of the American Red Cross are hard at work ... they endure that could potentially put Philadelphia,s blood supply ... strike and set up a picket line yesterday when ...
(Date:12/4/2009)... Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ... teleconference and webcast. Principal investigators will discuss the ... myeloma, as featured at the 51st American Society of ... at 9:00 a.m. CT/10:00 a.m. ET on Monday, December ...
(Date:12/4/2009)... CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ... to provide therapy equipment and rehab supplies to Benchmark ... Georgia. ,, "We are pleased to be named ... K. Beardall, executive vice president of sales and marketing ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 1U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 2U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 3U M Improved Preventive and Chronic Care and Saved Medicare 24 24 54727 4DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 1DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 2DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 3DURECT Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma 54723 4SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 1SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 2SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 3SailPoint Expands European Presence Through Partnerships and Customer Wins 54720 4
... NicOx S.A.,(Euronext Paris: COX) today announced its financial ... during the year. NicOx also,announced today the initiation of ... (see separate press release)., Key highlights 2007:, ... 3 trials for naproxcinod (the ...
... ROCKVILLE, Md., Feb. 29 A study ... genetic variation in the,Ciliary Neurotrophic Factor gene ... study, conducted by Vanda Pharmaceuticals,Inc., included patients ... either with Fiapta(TM) (iloperidone), a novel atypical,antipsychotic ...
Other Medicine Technology:Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 2Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 3Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 4Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 5Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 6Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 7Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 8Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 9Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 10Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 11Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 12Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 13Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 14Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs 15Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 2Genetic Variation Associated with Treatment Response in a Clinical Study of a New Atypical Antipsychotic Fiaptatm (iloperidone) 3
Shoulder rasp...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
... allows braided suture to be used in ... may be used with any type or ... with anchors or screws (including suture pre-assembled ... Relay can be passed through any conventional ...
Medicine Products: